The Practical Paraplegic

A clinical trial that would test the use of embryonic stem cells to treat spinal cord injury could begin within three months. The Scientist is reporting that the Food and Drug Administration (FDA) may lift its hold on a trial sponsored by California biotech Geron Corp. by early next year. In May, the agency ordered Geron to delay the trial while it studied how best to regulate stem-cell-based therapies.
Read more ….